NDC codes

FDA NDC Directory
Product NDC (as listed)68788-8227Labeler and product segments. Claims need a package NDC.
Product NDC at billing width68788-8227Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
68788-8227-168788822701100 TABLET in 1 BOTTLE (68788-8227-1)Marketed from Aug 8, 2022
68788-8227-36878882270330 TABLET in 1 BOTTLE (68788-8227-3)Marketed from Aug 8, 2022

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Methimazole
Generic name (nonproprietary)
methimazole
Active ingredients
Methimazole — 10 mg/1
Dosage form
Tablet
Route
Oral
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 040734
Marketing start
Listing expires
Other FDA classes
Thyroid Hormone Synthesis Inhibitors (Mechanism)
Identifiers
Product ID 68788-8227_dd549f3b-3a40-4d11-8278-bf6f1f368920SPL ID dd549f3b-3a40-4d11-8278-bf6f1f368920SPL set ID 244d76f1-98e6-4305-8768-b104f6a4be07RxCUI 197941UNII 554Z48XN5E
Pharmacologic class
Thyroid Hormone Synthesis Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468788822701 followed by a unit qualifier and the quantity

Package 68788-8227-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

INDICATIONS AND USAGE Methimazole tablets are indicated: • In patients with Graves' disease with hyperthyroidism or toxic multinodular goiter for whom surgery or radioactive iodine therapy is not an appropriate treatment option. • To ameliorate symptoms of hyperthyroidism in preparation for thyroidectomy or radioactive iodine therapy.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 040734

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 040734
ProductStrengthForm · routeLabelerProduct NDC
MethimazoleMethimazole 10 mg/1TabletOralBryant Ranch Prepack71335-0883
MethimazoleMethimazole 5 mg/1TabletOralBryant Ranch Prepack63629-8347
MethimazoleMethimazole 5 mg/1TabletOralNORTHSTAR RX LLC72603-315
MethimazoleMethimazole 10 mg/1TabletOralNORTHSTAR RX LLC72603-316
MethimazoleMethimazole 5 mg/1TabletOralGolden State Medical Supply, Inc.60429-380
MethimazoleMethimazole 10 mg/1TabletOralGolden State Medical Supply, Inc.60429-381
MethimazoleMethimazole 5 mg/1TabletOralPreferred Pharmaceuticals Inc.68788-8226
MethimazoleMethimazole 10 mg/1TabletOralProficient Rx LP82804-231
MethimazoleMethimazole 5 mg/1TabletOralA-S Medication Solutions50090-6536
MethimazoleMethimazole 10 mg/1TabletOralREMEDYREPACK INC.70518-1475
MethimazoleMethimazole 5 mg/1TabletOralREMEDYREPACK INC.70518-1506
MethimazoleMethimazole 10 mg/1TabletOralHeritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.23155-071
MethimazoleMethimazole 5 mg/1TabletOralHeritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.23155-070

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in